Global Respiratory Syncytial Virus Vaccines Market Size & Outlook
Global respiratory syncytial virus vaccines market, 2018-2030 (US$M)
Related Markets
Global respiratory syncytial virus vaccines market highlights
- The global respiratory syncytial virus vaccines market generated a revenue of USD 3,514.3 million in 2024 and is expected to reach USD 28,385.6 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 42.2% by 2030.
- In terms of segment, passive immunization accounted for a revenue of USD 3,586.5 million in 2024.
- Preventive Vaccines is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2024.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 3,514.3 million |
| Market revenue in 2030 | USD 28,385.6 million |
| Growth rate | 42.2% (CAGR from 2025 to 2030) |
| Largest segment | Passive immunization |
| Fastest growing segment | Preventive Vaccines |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Passive Immunization, Preventive Vaccines |
Other key industry trends
- In terms of revenue, the North America accounted for 28.5% of the global respiratory syncytial virus vaccines market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Mexico is the fastest growing regional market and is projected to reach USD 419.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Respiratory Syncytial Virus Vaccines Market Scope
Respiratory Syncytial Virus Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Blue Lake Biotechnology | View profile | 11-50 | Athens, Georgia, United States, North America | https://www.bluelakebiotechnology.com |
| Codagenix | View profile | 1-10 | Farmingdale, New York, United States, North America | http://codagenix.com |
| Meissa Vaccines | View profile | 11-50 | San Francisco, California, United States, North America | http://www.meissavaccines.com/ |
| Icosavax | View profile | 51-100 | Seattle, Washington, United States, North America | http://www.icosavax.com/ |
| Merck & Co., Inc. | View profile | - | - | - |
| Moderna Inc | View profile | 5600 | 200 Technology Square, Cambridge, MA, United States, 02139 | https://www.modernatx.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
Global respiratory syncytial virus vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to respiratory syncytial virus vaccines market will help companies and investors design strategic landscapes.
Passive immunization was the largest segment with a revenue share of 102.05% in 2024. Horizon Databook has segmented the Global respiratory syncytial virus vaccines market based on passive immunization, preventive vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Respiratory Syncytial Virus Vaccines Type Outlook (Revenue, USD Million, 2018-2030)
- Passive Immunization
- Preventive Vaccines
- Global Respiratory Syncytial Virus Vaccines Targeted Population Outlook (Revenue, USD Million, 2018-2030)
- Pediatric
- Adult
- Global Respiratory Syncytial Virus Vaccines Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital & Retail Pharmacies
- Government Suppliers
- Others
- Global Respiratory Syncytial Virus Vaccines Technology Outlook (Revenue, USD Million, 2018-2030)
- Monoclonal Antibodies
- Recombinant Protein + Adjuvant
- mRNA-Based Vaccine
- Virus-Like Particle (VLP)
Reasons to subscribe to Global respiratory syncytial virus vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global respiratory syncytial virus vaccines market databook
-
Our clientele includes a mix of respiratory syncytial virus vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global respiratory syncytial virus vaccines market , including forecasts for subscribers. This global databook contains high-level insights into Global respiratory syncytial virus vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global respiratory syncytial virus vaccines market size, by regions, 2018-2030 (US$M)
Top 10 countries: Respiratory syncytial virus vaccines market size, 2024 (US$M)
Global respiratory syncytial virus vaccines market share, by type, 2024 & 2030 (%, US$M)
Respiratory syncytial virus vaccines market: Opportunity assessment by country
Global respiratory syncytial virus vaccines market, by region, 2024 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
